Improving the Prediction of Coronary Heart Disease to Aid in the Management of High Cholesterol Levels
JAMAPublished 11 February 1998
Andrew L. Avins, Warren S. Browner
Citations37
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Simple modifications of the NCEP treatment criteria result in a substantially improved ability to discriminate between higher and lower CHD risk groups, and this revised system retains its classification ability in all age groups studied.
Abstract
Simple modifications of the NCEP treatment criteria result in a substantially improved ability to discriminate between higher and lower CHD risk groups. Unlike the NCEP system, this revised system retains its classification ability in all age groups studied.
Keywords
MedicineEconomics, Econometrics and Finance
JAMASummary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
27,886 Citations1993Scott M. Grundy
Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
RadiologyThe meaning and use of the area under a receiver operating characteristic (ROC) curve.
21,812 Citations1982J A Hanley, Barbara J. McNeil
A representation and interpretation of the area under a receiver operating characteristic (ROC) curve obtained by the "rating" method, or by mathematical predictions based on patient characteristics, is presented and it is shown that in such a setting the area represents the probability that a randomly chosen diseased subject is (correctly) rated or ranked with greater suspicion than a random chosen non-diseased subject.
ScienceMeasuring the Accuracy of Diagnostic Systems
10,020 Citations1988John A. Swets
For diagnostic systems used to distinguish between two classes of events, analysis in terms of the "relative operating characteristic" of signal detection theory provides a precise and valid measure of diagnostic accuracy.
New England Journal of MedicineThe Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
7,491 Citations1996Frank M. Sacks, Marc A. Pfeffer +10 more
It is demonstrated that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels and was also greater in patients with higher pretreatment levels of LDL cholesterol.
New England Journal of MedicinePrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
7,453 Citations1995James Shepherd, Stuart M. Cobbe +6 more
Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.
Clinical ChemistryReceiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
6,601 Citations1993M H Zweig, Gregory Campbell
Receiver-operating characteristic (ROC) plots provide a pure index of accuracy by demonstrating the limits of a test's ability to discriminate between alternative states of health over the complete spectrum of operating conditions.
CirculationAn updated coronary risk profile. A statement for health professionals.
1,864 Citations1991Keaven M. Anderson, P W Wilson +2 more
Using a simple worksheet, a patient's 5- and 10-year CHD risks can be estimated using components of the profile selected because they are objective and strongly and independently related to CHD.
American Journal of EpidemiologyHIGH DENSITY LIPOPROTEIN CHOLESTEROL AS A PREDICTOR OF CARDIOVASCULAR DISEASE MORTALITY IN MEN AND WOMEN: THE FOLLOW-UP STUDY OF THE LIPID RESEARCH CLINICS PREVALENCE STUDY
459 Citations1990David R. Jacobs, Irma Mebane +3 more
This study confirms both the importance and the independence in both men and women of HDL cholesterol in the epidemiology of coronary heart disease and other cardiovascular disease mortality.
JAMADeclining Serum Total Cholesterol Levels Among US Adults
458 Citations1993Clifford L. Johnson
The observed downward trend in serum cholesterol levels has coincided with a continuing decline in coronary heart disease mortality, suggesting that the Healthy People 2000 goal of reducing the mean serum cholesterol level of US adults to no more than 200 mg/dL (5.17 mmol/L) is attainable.
Annals of EpidemiologyCholesterol and heart disease in older persons and women review of an NHLBI workshop
356 Citations1992Teri A. Manolio, Thomas A. Pearson +4 more
Serum total cholesterol and low-density-lipoprotein (LDL) cholesterol levels predicted fatal CHD in middle-aged and older men and women, though the strength and consistency of these relationships in older women were diminished.
CirculationCost and health implications of cholesterol lowering.
211 Citations1992Lee Goldman, David J. Gordon +6 more
High priority should be given to research that could validate these cost-effectiveness projections as well as to further studies of the elderly and women, in whom direct data on the precise costs, risks, and benefits of interventions to lower cholesterol remain sparse.
BMJWho benefits from medical interventions?
129 Citations1994George Davey Smith, Matthias Egger
The results of clinical trials are often expressed in relative terms - for example, a particular treatment reduces the risk of an adverse outcome from 5% to 3% (an absolute reduction of 2%) - but when the results are presented as the number of patients who need to be treated for one non-fatal myocardial infarction to be avoided they look very different.
Annals of Internal MedicineCLINICAL GUIDELINE, PART 2: Cholesterol Screening in Asymptomatic Adults, Revisited
117 Citations1996Alan M. Garber, Warren S. Browner +1 more
These findings reinforce laboratory, physiologic, and epidemiologic evidence that cholesterol has a causal role in the development of coronary heart disease and show that cholesterol-lowering therapies can mitigate the effects of high blood cholesterol levels on the illness and death caused by coronary heart Disease.
American Journal of EpidemiologyFAMILY HISTORY OF CORONARY HEART DISEASE: IS IT AN INDEPENDENT RISK FACTOR?
66 Citations1986Kenneth A. Perkins
Medical Decision MakingResampling Techniques in the Analysis of Non-binormal ROC Data
59 Citations1995Douglas Mossman
This article describes the plication of resampling techniques to ROC data for which the binormal assumptions are not appropriate, and suggests that the bootstrap may be especially helpful in determining confidence intervals from small data samples.
International Journal of Technology Assessment in Health CareA Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering Treatment
53 Citations1992Henry A. Glick, Joseph F. Heyse +4 more
Standard incidence-based techniques for measuring the cost of illness with logistic risk functions from the Framingham Heart Study are combined to project the likelihood of developing coronary heart disease over a lifetime as well as a number of related outcomes, including the expected loss of years of life due to CHD.
Journal of General Internal MedicineMismatch of coronary risk and treatment intensity under the national cholesterol education program guidelines
17 Citations1991Warren J. McIsaac, C. David Naylor +1 more
Inconsistencies exist in the NCEP guidelines such that persons at low risk for the development of CHD are offered more intensive interventions than are others who actually are at much higher risks, and vice versa.
Annals of Internal MedicineLowering Risk without Lowering Cholesterol: Implications for National Cholesterol Policy
16 Citations1996Andrew L. Avins, Warren S. Browner
The effects of such interventions as aspirin therapy, which reduce the risk for coronary heart disease but that are not used primarily because of lipid-altering effects, have not been considered during the development of policies on cholesterol.
The American Journal of CardiologyEditorial
8 Citations1997James S. Forrester, Prediman K. Shah
The guidelines ignore the common catastrophic first presentation of coronary disease, the powerful predictive value of serum cholesterol in young persons, the effectiveness of cholesterol-lowering interventions, the low cost of effective dietary modification, and the effective of lipid lowering in women and in the elderly.